Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
AgeX Therapeutics, Inc. (AGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "AgeX Therapeutics Reports Second Quarter 2023 Financial Results ALAMEDA, Calif.——August 14, 2023—AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30, 2023. Balance Sheet Information"
05/12/2023 8-K Quarterly results
Docs: "AgeX Therapeutics Reports First Quarter 2023 Financial Results ALAMEDA, Calif.——May 12, 2023—AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023. Balance Sheet Information"
03/31/2023 8-K Quarterly results
Docs: "AGEX THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS"
11/10/2022 8-K Quarterly results
08/12/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
03/29/2022 8-K Quarterly results
Docs: "AGEX THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS"
11/12/2021 8-K Quarterly results
Docs: "AGEX THERAPEUTICS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2021 December 31, 2020 ASSETS CURRENT ASSETS Cash and cash equivalents $ 731 $ 527 Accounts and grants receivable, net 24 326 Prepaid expenses and other current assets 720 1,430 Total current assets 1,475 2,283 Deposits and other long-term assets 50 50 Intangible assets, net 902 1,592 TOTAL ASSETS $ 2,427 $ 3,925 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued liabilities $ 924 $ 1,656 Loan due to Juvenescence, net of debt issuance cost, current portion 5,600 1,960 Related party payables, net 71 71 Deferred revenues, current portion - 275 Paycheck Protection Program Loan - 436 Insurance premium liability and other current liabilities 3 959 Total current liabil..."
08/13/2021 8-K Quarterly results
03/31/2021 8-K Quarterly results
11/16/2020 8-K Quarterly results
Docs: "AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/14/2020 8-K Quarterly results
05/14/2020 8-K Quarterly results
Docs: "AgeX Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update"
11/14/2019 8-K Quarterly results
08/14/2019 8-K Quarterly results
05/15/2019 8-K Quarterly results
Docs: "AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update"
04/01/2019 8-K Quarterly results
Docs: "AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy